Quartesian Clinical Research Private Limited, a amalgamated private limited company, was established on 02 September 2004 in Bangalore, Karnataka, India. Engaging in business process outsourcing within the professional, scientific and technical sector, it holds CIN: U73100KA2004PTC034625. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.35 M.
It upholds a compliant status. Employing 231 professional, Its leadership includes Benjamin Jackson Francis (Director), John Maria Xavier (Director), Thiyagarajan Ramasamy (Director). Past directors included Arun Shankar Chowdhury, Nirmal Arockiaraj. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at No. 23 & 24,2Nd Floor,Amr Techpark 1A, Hongasandra,Hosur Main Road, Bangalore, Karnataka, 560068.
U73100KA2004PTC034625
034625
02 September 2004
₹0.50 M
₹0.35 M
Roc Bangalore
Unlisted
Amalgamated
Explore comprehensive insights into Quartesian Clinical Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Benjamin Jackson Francis | Director | 22 Dec 2007 | Current |
| John Maria Xavier | Director | 02 Sep 2004 | Current |
| Thiyagarajan Ramasamy | Director | 20 Nov 2014 | Current |
| Soumitra Chowdhury Shankar | Director | 02 Sep 2004 | Current |
| Vladimir Mats | Director | 22 Dec 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Dec 2014 | Past |
| Pramod Abcsdd | Director | 10 Dec 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Quartesian Clinical Research Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 21.66% increase. The company also saw a slight improvement in profitability, with a 9.57% increase in profit. The company's net worth Soared by an impressive increase of 45.93%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Quartesian Clinical Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Quartesian Clinical Research has a workforce of 231 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Quartesian Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quartesian Clinical Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Quartesian Clinical Research Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was documented.
Quartesian Clinical Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Bangalore. was recorded as a recent event.
Thiyagarajan Ramasamy was appointed as a Director was appointed as a Director on 20 Nov 2014 & has been associated with this company since 11 years 15 days . was recorded as a recent event.
Progress on Benjamin Jackson Francis was appointed as a Director was appointed as a Director on 22 Dec 2007 & has been associated with this company since 17 years 11 months . was documented.
Vladimir Mats was appointed as a Director was appointed as a Director on 22 Dec 2007 & has been associated with this company since 17 years 11 months . was recorded as a recent event.
John Maria Xavier was appointed as a Director was appointed as a Director on 02 Sep 2004 & has been associated with this company since 21 years 3 months . was recorded as a recent event.
The CIN of Quartesian Clinical Research Private Limited is U73100KA2004PTC034625.
Quartesian Clinical Research Private Limited is headquartered at No. 23 & 24,2Nd Floor,Amr Techpark 1A, Hongasandra,Hosur Main Road, Bangalore, Karnataka, 560068.
Quartesian Clinical Research Private Limited was incorporated on 02 September 2004.
The current directors of Quartesian Clinical Research Private Limited are
The primary industry of Quartesian Clinical Research Private Limited is Professional, Scientific And Technical.
Quartesian Clinical Research Private Limited is unlisted.
The authorized capital of Quartesian Clinical Research Private Limited is ₹0.50 M, and the paid-up capital is ₹0.35 M.
The compliance status of Quartesian Clinical Research Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX